Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Does my patient have amyloid cardiomyopathy? ++ Table Graphic Jump Location|Download (.pdf)|Print The diagnosis of amyloid cardiomyopathy is based on symptomatology, echocardiogram findings, and tissue biopsy. HPI: Dyspnea, fatigue, syncope, easy bruising. PMH: AL (primary) amyloidosis. FH: Familial amyloidosis. Peripheral edema, hepatomegaly, hypotension, elevated jugular venous pressure, periorbital purpura, skin bruising. Low voltage, atrial fibrillation. ECHO: Granular sparkling appearance of myocardium, thickened left ventricle, thickened and dilated right ventricle, mitral and aortic valve leaflet thickening. AC = Amyloid Cardiomyopathy. SYMP = SYMPtoms of dyspnea, fatigue, and/or syncope. ECHO = ECHOcardiogram findings of granular sparkling myocardium, thickened left and right ventricular, mitral and aortic valve leaflet thickening. NCARD-BX = Non-CARDiac tissue and/or (abdominal fat pad, rectum, or kidney) Biopsy positive for amyloid deposits. IN-NCARD-BX = INconclusive Non-CARDiac tissue Biopsy. CARD-BX = EndomyoCARDial Biopsy positive for amyloid deposits. SYMP + ECHO + NCARD-BX = AC SYMP + ECHO + IN-NCARD-BX + CARD-BX = AC Cardiac amyloidosis should be ruled out in any patient with unexplained heart failure and increased wall thickness on echocardiogram, especially if other clues are present, such as nephrotic syndrome or atrial fibrillation. – Endomyocardial biopsy is virtually 100% sensitive in amyloid cardiomyopathy as amyloid will be deposited throughout the heart. – In patients with known amyloid deposits in other organs and a history of hypertension, there may be uncertainty as to whether ventricular thickening represents amyloid infiltration or hypertensive heart disease. In such cases, a biopsy may be helpful to determine whether patient has AC. 1. Falk RH. Diagnosis and management of the cardiac amyloidosis. Circulation. 2005;112:2047–2060. +++ How do I manage my patient with atypical angina (cardiac syndrome X)? ++ Table Graphic Jump Location|Download (.pdf)|Print The management of cardiac syndrome X is based upon pain relief with medication and risk factor reduction. HPI: Chest pain/discomfort precipitated by exercise or at rest lasting average of 10 minutes. PMH: Hypertension, hyperlipidemia, diabetes. SH: Alcohol, smoking. ECG: Normal findings when asymptomatic. ST-segment depression with angina pain. Exercise stress test: exercise ECG is horizontal or downsloping ST-segment depression. Coronary angiogram: Normal coronary arteries (<30% stenosis). Cardiac MRI: Subendocardial perfusion defects. RF-RED = Risk Factor REDuction: smoking, hypertension, hyperlipidemia, obesity, physical inactivity. ATEN = ATENolol 100 mg/day for 4 weeks. AMLO = AMLOdipine 10 mg/day. NITR = isosorbide monoNITRate 10 mg BID or SL-NTG 0.4 mg. CSX = Cardiac Syndrome X. CSX = RF-RED +/– ATEN/AMLO/NITR Cardiac syndrome X is believed to be caused by microvascular disease (<30% stenosis), endothelial dysfunction, and enhanced pain perception. Risk factors are obesity, hypertension, dyslipidemia, glucose intolerance, and proinflammatory states. It is characterized by decrease in coronary flow reserve without epicardial stenosis. Syndrome X rarely causes myocardial infarction and it has a good prognosis. 10–20% of patients with ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.